Senior Director, Global Strategy

PROCEPT BioRobotics is a commercial-stage surgical robotics company centered on revolutionizing patient care through transformative solutions in urology. Founded in 2007, the company specializes in the development and manufacturing of the HYDROS Robotic System, which is designed to aid in minimally invasive surgical procedures and treats Benign Prostatic Hyperplasia (BPH). With an emphasis on safety and efficacy, Aquablation therapy utilizes advanced imaging and robotic technology to deliver precise treatment, ensuring better outcomes for patients.

The HYDROS Robotic System is a cutting-edge platform that integrates computer-assisted treatment planning with real-time imaging capabilities. This unique technology allows surgeons to tailor the therapy to meet the individual needs of their patients, thus maximizing tissue preservation while effectively removing prostate tissue. The result is significant symptom relief for men suffering from urinary tract issues, independent of prostate size or a surgeon's experience. PROCEPT BioRobotics is committed to providing state-of-the-art solutions that prioritize the health and well-being of patients, enabling men to reclaim their quality of life with improved urinary function.